A new Vitamin D eye drop has been launched in India to treat dry eye syndrome, a common eye ailment. Launched by ENTOD Pharmaceuticals, the new formulation provides targeted relief to people suffering from dry eyes and marks a breakthrough in eye health, the company said in a statement.
Vitamin D3 is currently incorporated into some of ENTOD Pharmaceutical’s select lubricant eye drop brands prescribed by ophthalmologists to treat dry eye, according to the company.
Dry eye syndrome is a common condition characterized by discomfort, irritation and even vision problems. The main causes of dry eyes are environmental factors, vitamin deficiencies, poor blinking habits, contact lenses, digital devices, smoking and refractive surgery.
Government-run Janaushadhi stores give tough fight to private pharmacies
ICMR proposes new guidelines to limit sugar content in packaged foods and beverages
If you’re dehydrated, only consume WHO-recommended ORS: Doctors warn against sugary drinks
India heatwave: Hospitals report surge in heatstroke cases as temperatures continue to rise
“As a pharmaceutical company committed to improving healthcare outcomes, we recognized the urgent need for an effective solution to address dry eye syndrome. By harnessing the power of Vitamin D3 and other key ingredients, we aim to provide effective relief to those suffering from dry eye and ultimately improve their quality of life. The addition of Vitamin D3 to regular dry eye treatment improves ocular surface hemostatic parameters, enhances tear stability and increases tear osmolality.”
It helps regulate corneal wound healing. Our Vitamin D3 enriched lubricating eye drops are available only through a prescription from a healthcare professional. Our passion for innovation and excellence is leading us in providing effective interventions to enable individuals to protect their vision,” said Nikkhil K Masurkar, CEO, ENTOD Pharmaceuticals.
According to Dr Ganesh Kalyanshetty, cataract and cornea surgeon at KMC Eye and Skin Hospital, Navi Mumbai, vitamin D deficiency is increasingly being recognised as a major cause of various eye diseases, including dry eye syndrome.
“Deficiency of Vitamin D not only leads to poor tear production but also compromises the health of the ocular surface making people more susceptible to discomfort and vision problems. The launch of Vitamin D3 enriched lubricating eye drops by ENTOD Pharmaceuticals marks a significant moment in addressing these issues. This advancement has the potential to improve the ocular health and overall wellness of countless people across the country,” said Dr. Kalyan Shetty.
Vitamin D3 deficiency is a widespread problem, especially in areas with limited exposure to sunlight like India. Studies have shown that a lack of Vitamin D3 can adversely affect eye health and lead to conditions like age-related macular degeneration, diabetic retinopathy and dry eye syndrome.
According to a report released in May 2020, around 76% of Indians suffer from vitamin D deficiency or insufficiency, with the prevalence highest among young adults.
Recognizing the important role that Vitamin D plays in maintaining overall health, ENTOD said it aims to address this pressing issue through its innovative eye care solutions.
